April 2024
1. QASEEM A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte JE, et al
   Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians (Version 1, Update Alert).
   Ann Intern Med. 2024;177:eL230440.
   

   >> Share

   
   
2. DOBRESCU AI, Persad E, Klerings I, Gartlehner G, et al
   Update Alert: Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians.
   Ann Intern Med. 2024;177:eL230441.
   

   >> Share

   
   
3. QASEEM A, Andrews RA, Campos K, Goldzweig CL, et al
   Quality Indicators for Major Depressive Disorder in Adults: A Review of Performance Measures by the American College of Physicians.
   Ann Intern Med. 2024;177:507-513.
   

   >> Share

   
   January 2024
4. ISHIGUCHI H, Lip GYH
   In symptomatic AF, catheter ablation vs. medical therapy reduced depression and anxiety symptoms at 12 mo.
   Ann Intern Med. 2024 Jan 2. doi: 10.7326/J23-0105.
   

   >> Share

   
   September 2023
5. HOLSINGER T, Riordan P
   In treatment-resistant major depression, ketamine was noninferior to ECT for treatment response.
   Ann Intern Med. 2023 Sep 5. doi: 10.7326/J23-0068.
   

   >> Share

   
   February 2023
6. QASEEM A, Owens DK, Etxeandia-Ikobaltzeta I, Tufte J, et al
   Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians.
   Ann Intern Med. 2023;176:239-252.
   

   >> Share

   
   
7. GARTLEHNER G, Dobrescu A, Chapman A, Toromanova A, et al
   Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians.
   Ann Intern Med. 2023;176:196-211.
   

   >> Share

   
   
8. AFFENGRUBER L, Wagner G, Dobrescu A, Toromanova A, et al
   Values and Preferences of Patients With Depressive Disorders Regarding Pharmacologic and Nonpharmacologic Treatments : A Rapid Review.
   Ann Intern Med. 2023;176:217-223.
   

   >> Share

   
   
9. DOBRESCU A, Chapman A, Affengruber L, Persad E, et al
   Cost-Effectiveness of First- and Second-Step Treatment Strategies for Major Depressive Disorder : A Rapid Review.
   Ann Intern Med. 2023;176:212-216.
   

   >> Share

   
   January 2023
10. 
    Summary for Patients: Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depression.
    Ann Intern Med. 2023 Jan 24. doi: 10.7326/P22-0027.
    

    >> Share

    
    
11. SHUCHMAN M, Abi-Jaoude E
    The American College of Physicians Living Guideline on Depression: A Step Forward, but Gaps Remain.
    Ann Intern Med. 2023 Jan 24. doi: 10.7326/M22-3701.
    

    >> Share

    
    October 2022
12. SALANTI G, Peter N, Tonia T, Holloway A, et al
    The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population : A Systematic Review and Dose-Response Meta-analysis.
    Ann Intern Med. 2022 Oct 18. doi: 10.7326/M22-1507.
    

    >> Share

    
    
13. MCQUAID JR, Buelt A, Capaldi V, Fuller M, et al
    The Management of Major Depressive Disorder: Synopsis of the 2022 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2022;175:1440-1451.
    

    >> Share

    
    January 2022
14. FANG Y, Bohnert ASB, Pereira-Lima K, Cleary J, et al
    Trends in Depressive Symptoms and Associated Factors During Residency, 2007 to 2019 : A Repeated Annual Cohort Study.
    Ann Intern Med. 2022;175:56-64.
    

    >> Share

    
    August 2021
15. HIRSCH C
    In patients with dementia and depression, several nondrug interventions vs. usual care reduce depression symptoms.
    Ann Intern Med. 2021 Aug 3. doi: 10.7326/ACPJ202108170.
    

    >> Share

    
    July 2021
16. WATT J
    In older adults with subclinical hypothyroidism, levothyroxine therapy did not reduce depressive symptoms at 12 mo.
    Ann Intern Med. 2021;174:JC81.
    

    >> Share

    
    May 2021
17. MCCARRON RM, Shapiro B, Rawles J, Luo J, et al
    Depression.
    Ann Intern Med. 2021 May 11. doi: 10.7326/AITC202105180.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share